IL10 and inflammatory bowel disease: In this study, we investigated if the presence of an IBD-associated pathobiont (AIEC)13,40 would exacerbate intestinal inflammation and worsen symptoms triggered by subsequent administration of NSAIDs in IL10−/− mice.